BZH

Beazer Homes USA Inc
NYSECONSUMER CYCLICALRESIDENTIAL CONSTRUCTION

Key Statistics

Market Cap
$890.30M
P/E Ratio
—
EPS
$-0.36
Beta
2.18
52W High
$34.54
52W Low
$17.83
50-Day MA
$33.15
200-Day MA
$25.98
Dividend Yield
—
Profit Margin
-0.37%
Forward P/E
17.51
PEG Ratio
1.46

About Beazer Homes USA Inc

Beazer Homes USA, Inc. is a home builder in the United States. The company is headquartered in Atlanta, Georgia.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$2.08B
Gross Profit (TTM)$266.96M
EBITDA$-10.32M
Operating Margin-1.75%
Return on Equity-0.65%
Return on Assets-0.65%
Revenue/Share (TTM)$74.02
Book Value$43.40
Price-to-Book0.78
Price-to-Sales (TTM)0.43
EV/Revenue1.057
EV/EBITDA76.61
Quarterly Earnings Growth (YoY)-39.90%
Quarterly Revenue Growth (YoY)-5.30%
Shares Outstanding$26.68M
Float$23.74M
% Insiders8.87%
% Institutions93.50%

Historical Volatility

HV 10-Day
2.00%
HV 20-Day
1.62%
HV 30-Day
2.25%
HV 60-Day
29.74%
HV Rank
0.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($27.50 target)
1
Buy
1
Hold

Latest News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

BALA CYNWYD, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire9/24/2026Neutral
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire9/9/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BZH and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER CYCLICAL Stocks

Data last updated: 9/26/2026